The impact of an innovative pharmacist-led inpatient opioid de-escalation intervention in post-operative orthopedic patients.
Journal
Journal of opioid management
ISSN: 1551-7489
Titre abrégé: J Opioid Manag
Pays: United States
ID NLM: 101234523
Informations de publication
Date de publication:
Historique:
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
27
10
2020
Statut:
ppublish
Résumé
Many patients are discharged from hospital after surgery with excessive doses of opioid, and prescription opioid addiction has become a serious public health problem. Inpatient opioid de-escalation performed by clinical phar-macists may assist in reducing opioids before discharge. We aimed to evaluate whether clinical pharmacist-led opioid de-escalation for inpatients after orthopedic surgery led to significant reductions in opioid use at discharge, without resulting in greater pain intensity and side effects. This retrospective pre-/post-intervention study evaluated patients before and after implementation of a phar-macist-led opioid de-escalation service. A major tertiary institution. Ninety eight participants underwent de-escalation, and 98 controls received standard care following ortho-pedic surgery. Pharmacist-led opioid de-escalation was initiated after discharge from the institution's Acute Pain Service. Primary outcome was total morphine oral equivalence (MOE) required in the 24-hours before discharge between the two groups. Secondary outcomes included pain intensity scores and opioid-related side effects. The post-intervention group used significantly less opioids in the 24 hours preceding discharge compared with the precohort (total MOE 30 vs 45 mg; p = 0.025).There were no differences in pain intensity at rest (p = 0.19) or with movement (p = 0.19). Cases experienced significantly less constipation (29 vs 49 percent; p = 0.004); no differences were observed for other side effects. We observed statistically similar pain intensity ratings, in the setting of significantly lowered opioid doses among the post-intervention group prior to discharge. Pharmacist-led inpatient opioid de-escalation is effective, does not increase pain intensity, and reduces constipation. Hospitals should explore the viability of extending pharmacist-led opioid de-escalation to other surgical patients and following hospital discharge, aiming for opioid cessation.
Identifiants
pubmed: 32421837
pii: jom.2020.0565
doi: 10.5055/jom.2020.0565
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM